Robots, computers, and algorithms are hunting for potential new therapies in ways humans can’t—by processing huge volumes of data and building previously unimagined molecules.

machine learning algorithm designs antibodies to target specific diseases, then automated robotic systems build and grow them in lab, run tests, and feed data back into algorithm, all with limited human supervision.